These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| State of |
|
|
|||||||||
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer
Identification No.) |
||||||||||
|
|
|
|
|
||||||||
| (Address of principal executive offices) | (Zip code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
| Page | ||||||||
| Condensed Consolidated Statements of Changes in Equity (Unaudited) | ||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
|
Net sales
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Cost of sales
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Gross margin
|
|
|
|
|
|||||||||||||||||||
|
Selling, general and administrative expenses
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Restructuring and impairment
|
(
|
|
(
|
|
|||||||||||||||||||
|
Interest expense
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Interest income
|
|
|
|
|
|||||||||||||||||||
|
Equity in net (loss) income of non-consolidated affiliates
|
(
|
|
|
|
|||||||||||||||||||
|
Other income, net
|
|
|
|
|
|||||||||||||||||||
|
Income (loss) before income taxes
|
|
|
|
|
|||||||||||||||||||
|
Provision for income taxes
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Net income (loss)
|
|
|
|
|
|||||||||||||||||||
|
Less: Net (income) loss attributable to non-controlling interests
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Net income (loss) attributable to Visteon Corporation
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Comprehensive income (loss)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Less: Comprehensive (income) loss attributable to non-controlling interests |
|
(
|
|
(
|
|||||||||||||||||||
|
Comprehensive income (loss) attributable to Visteon Corporation
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Basic earnings (loss) per share attributable to Visteon Corporation
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Diluted earnings (loss) per share attributable to Visteon Corporation
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| (Unaudited) | |||||||||||
| September 30, | December 31, | ||||||||||
| 2022 | 2021 | ||||||||||
| ASSETS | |||||||||||
|
Cash and equivalents
|
$ |
|
$ |
|
|||||||
|
Restricted cash
|
|
|
|||||||||
|
Accounts receivable, net
|
|
|
|||||||||
|
Inventories, net
|
|
|
|||||||||
|
Other current assets
|
|
|
|||||||||
|
Total current assets
|
|
|
|||||||||
|
Property and equipment, net
|
|
|
|||||||||
|
Intangible assets, net
|
|
|
|||||||||
|
Right-of-use assets
|
|
|
|||||||||
|
Investments in non-consolidated affiliates
|
|
|
|||||||||
|
Other non-current assets
|
|
|
|||||||||
|
Total assets
|
$ |
|
$ |
|
|||||||
| LIABILITIES AND EQUITY | |||||||||||
|
Short-term debt
|
$ |
|
$ |
|
|||||||
|
Accounts payable
|
|
|
|||||||||
|
Accrued employee liabilities
|
|
|
|||||||||
|
Current lease liability
|
|
|
|||||||||
|
Other current liabilities
|
|
|
|||||||||
|
Total current liabilities
|
|
|
|||||||||
|
Long-term debt, net
|
|
|
|||||||||
|
Employee benefits
|
|
|
|||||||||
|
Non-current lease liability
|
|
|
|||||||||
|
Deferred tax liabilities
|
|
|
|||||||||
|
Other non-current liabilities
|
|
|
|||||||||
|
Stockholders’ equity:
|
|||||||||||
|
Preferred stock (par value
|
|
|
|||||||||
|
Common stock (par value $
|
|
|
|||||||||
|
Additional paid-in capital
|
|
|
|||||||||
|
Retained earnings
|
|
|
|||||||||
|
Accumulated other comprehensive loss
|
(
|
(
|
|||||||||
|
Treasury stock
|
(
|
(
|
|||||||||
|
Total Visteon Corporation stockholders’ equity
|
|
|
|||||||||
|
Non-controlling interests
|
|
|
|||||||||
|
Total equity
|
|
|
|||||||||
|
Total liabilities and equity
|
$ |
|
$ |
|
|||||||
| Nine Months Ended September 30, | |||||||||||
| 2022 | 2021 | ||||||||||
|
Operating Activities
|
|||||||||||
|
Net income (loss)
|
$ |
|
$ |
|
|||||||
|
Adjustments to reconcile net income (loss) to net cash provided from (used by) operating activities:
|
|||||||||||
|
Depreciation and amortization
|
|
|
|||||||||
|
Non-cash stock-based compensation
|
|
|
|||||||||
|
Equity in net loss (income) of non-consolidated affiliates, net of dividends remitted
|
— |
|
|||||||||
|
Impairments
|
|
|
|||||||||
|
Other non-cash items
|
(
|
|
|||||||||
|
Changes in assets and liabilities:
|
|||||||||||
|
Accounts receivable
|
(
|
|
|||||||||
|
Inventories
|
(
|
(
|
|||||||||
|
Accounts payable
|
|
(
|
|||||||||
|
Other assets and other liabilities
|
(
|
(
|
|||||||||
|
Net cash (used by) provided from operating activities
|
|
(
|
|||||||||
|
Investing Activities
|
|||||||||||
|
Capital expenditures, including intangibles
|
(
|
(
|
|||||||||
| Contributions to equity method investments |
(
|
(
|
|||||||||
| Settlement of derivative contracts |
|
|
|||||||||
| Loan repayments from non-consolidated affiliates |
|
|
|||||||||
| Other |
|
|
|||||||||
|
Net cash used by investing activities
|
(
|
(
|
|||||||||
|
Financing Activities
|
|||||||||||
| Borrowings on term debt facility |
|
|
|||||||||
| Payments on term debt facility |
(
|
|
|||||||||
| Dividends to non-controlling interests |
|
(
|
|||||||||
| Short-term debt, net |
(
|
|
|||||||||
| Other |
(
|
|
|||||||||
|
Net cash (used by) provided from financing activities
|
(
|
(
|
|||||||||
|
Effect of exchange rate changes on cash
|
(
|
(
|
|||||||||
|
Net decrease in cash, equivalents, and restricted cash
|
(
|
(
|
|||||||||
|
Cash, equivalents, and restricted cash at beginning of the period
|
|
|
|||||||||
|
Cash, equivalents, and restricted cash at end of the period
|
$ |
|
$ |
|
|||||||
| Total Visteon Corporation Stockholders' Equity | |||||||||||||||||||||||||||||||||||||||||||||||
|
Common
Stock |
Additional
Paid-In Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Income (Loss) |
Treasury
Stock |
Total Visteon Corporation Stockholders' Equity | Non-Controlling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||||||
|
December 31, 2021
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income (loss) | — | — |
|
— | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — |
|
— |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Stock-based compensation, net | — |
(
|
— | — |
|
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
March 31, 2022
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income (loss) | — | — |
|
— | — |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — |
(
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Stock-based compensation, net | — |
|
— | — |
|
|
— |
|
|||||||||||||||||||||||||||||||||||||||
| Dividends to non-controlling interest | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| June 30, 2022 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income (loss) | — | — |
|
— | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — |
(
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Stock-based compensation, net | — |
|
— | — |
|
|
— |
|
|||||||||||||||||||||||||||||||||||||||
| September 30, 2022 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Total Visteon Corporation Stockholders' Equity | |||||||||||||||||||||||||||||||||||||||||||||||
|
Common
Stock |
Additional
Paid-In Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Income (Loss) |
Treasury
Stock |
Total Visteon Corporation Stockholders' Equity | Non-Controlling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||||||
|
December 31, 2020
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
|
Net income (loss)
|
— | — |
|
— | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
— | — | — |
(
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Stock-based compensation, net | — |
(
|
— | — |
|
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
| Dividends to non-controlling interest | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
|
March 31, 2021
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income (loss) | — | — |
(
|
— | — |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — |
|
— |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Stock-based compensation, net | — |
|
— | — |
|
|
— |
|
|||||||||||||||||||||||||||||||||||||||
| Cash dividend | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Dividends to non-controlling interest | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| June 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income (loss) | — | — |
|
— | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — |
(
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Stock-based compensation, net | — |
|
— | — |
|
|
— |
|
|||||||||||||||||||||||||||||||||||||||
| September 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
|
Yanfeng Visteon Investment Co., Ltd. ("YFVIC") (
|
$ |
|
$ |
|
|||||||
| Limited partnerships |
|
|
|||||||||
|
Other
|
|
|
|||||||||
|
Total investments in non-consolidated affiliates
|
$ |
|
$ |
|
|||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
|
Payables due to YFVIC
|
$ |
|
$ |
|
|||||||
|
Exposure to loss in YFVIC:
|
|||||||||||
|
Investment in YFVIC
|
$ |
|
$ |
|
|||||||
|
Receivables due from YFVIC
|
|
|
|||||||||
|
Maximum exposure to loss in YFVIC
|
$ |
|
$ |
|
|||||||
| (In millions) | |||||||||||||||||
| December 31, 2021 | $ |
|
|||||||||||||||
| Expense |
|
||||||||||||||||
| Change in estimate |
|
||||||||||||||||
| Payments |
(
|
||||||||||||||||
| March 31, 2022 | $ |
|
|||||||||||||||
| Expense |
|
||||||||||||||||
| Change in estimate |
|
||||||||||||||||
| Payments |
(
|
||||||||||||||||
| Foreign exchange |
(
|
||||||||||||||||
| June 30, 2022 | $ |
|
|||||||||||||||
| Expense |
|
||||||||||||||||
| Payments |
(
|
||||||||||||||||
| September 30, 2022 | $ |
|
|||||||||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
|
Raw materials
|
$ |
|
$ |
|
|||||||
|
Work-in-process
|
|
|
|||||||||
|
Finished products
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| September 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||
| (In millions) | Estimated Weighted Average Useful Life (years) | Gross Intangibles | Accumulated Amortization | Net Intangibles | Gross Intangibles | Accumulated Amortization | Net Intangibles | ||||||||||||||||||||||||||||||||||
| Definite-Lived: | |||||||||||||||||||||||||||||||||||||||||
| Developed technology |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||
| Customer related |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Capitalized software development |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Other |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Subtotal |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Indefinite-Lived: | |||||||||||||||||||||||||||||||||||||||||
| Goodwill |
|
— |
|
|
— |
|
|||||||||||||||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
|
Receivables from non-consolidated affiliates
|
$ |
|
$ |
|
|||||||
|
Recoverable taxes
|
|
|
|||||||||
|
Contractually reimbursable engineering costs
|
|
|
|||||||||
|
Prepaid assets and deposits
|
|
|
|||||||||
| Royalty agreements |
|
|
|||||||||
| China bank notes |
|
|
|||||||||
|
Other
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
| Deferred tax assets | $ |
|
$ |
|
|||||||
| Contractually reimbursable engineering costs |
|
|
|||||||||
| Derivative financial instruments |
|
|
|||||||||
| Recoverable taxes |
|
|
|||||||||
| Pension assets |
|
|
|||||||||
| Royalty agreements |
|
|
|||||||||
|
Other
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
|
Deferred income
|
$ |
|
$ |
|
|||||||
|
Payables to non-consolidated affiliates
|
|
|
|||||||||
|
Non-income taxes payable
|
|
|
|||||||||
|
Product warranty and recall accruals
|
|
|
|||||||||
|
Income taxes payable
|
|
|
|||||||||
|
Royalty reserves
|
|
|
|||||||||
|
Restructuring reserves
|
|
|
|||||||||
|
Other
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
|
Product warranty and recall accruals
|
$ |
|
$ |
|
|||||||
|
Deferred income
|
|
|
|||||||||
|
Income tax reserves
|
|
|
|||||||||
| Restructuring reserves |
|
|
|||||||||
|
Royalty agreements
|
|
|
|||||||||
|
Derivative financial instruments
|
|
|
|||||||||
|
Other
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
| Short-Term Debt: | |||||||||||
| Current portion of long-term debt | $ |
|
$ |
|
|||||||
| Short-term borrowings |
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| Long-Term Debt: | |||||||||||
| Term debt facility, net | $ |
|
$ |
|
|||||||
| U.S. Plans | Non-U.S. Plans | ||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
|
Costs Recognized in Income:
|
|||||||||||||||||||||||
|
Pension service (cost):
|
|||||||||||||||||||||||
|
Service cost
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
|
Pension financing benefits (cost):
|
|||||||||||||||||||||||
|
Interest cost
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Expected return on plan assets |
|
|
|
|
|||||||||||||||||||
|
Amortization of losses and other
|
— | — | — |
(
|
|||||||||||||||||||
| Total pension financing benefits: |
|
|
— | — | |||||||||||||||||||
| Net pension benefit (cost) | $ |
|
$ |
|
$ | — | $ |
(
|
|||||||||||||||
| U.S. Plans | Non-U.S. Plans | ||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
|
Costs Recognized in Income:
|
|||||||||||||||||||||||
|
Pension service (cost):
|
|||||||||||||||||||||||
|
Service cost
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Pension financing benefits (costs):
|
|||||||||||||||||||||||
|
Interest cost
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Expected return on plan assets |
|
|
|
|
|||||||||||||||||||
|
Amortization of losses and other
|
— |
(
|
(
|
(
|
|||||||||||||||||||
| Total pension financing benefits: |
|
|
— | — | |||||||||||||||||||
| Net pension benefit (cost) | $ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| September 30, | December 31, | ||||||||||
| (In millions) | 2022 | 2021 | |||||||||
| Shanghai Visteon Automotive Electronics, Co., Ltd. | $ |
|
$ |
|
|||||||
| Yanfeng Visteon Automotive Electronics Co., Ltd. |
|
|
|||||||||
|
Changchun Visteon FAWAY Automotive Electronics, Co., Ltd.
|
|
|
|||||||||
|
Other
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
|
Changes in AOCI:
|
|||||||||||||||||||||||
|
Beginning balance
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Other comprehensive income (loss) before reclassification, net of tax
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Amounts reclassified from AOCI
|
|
|
|
|
|||||||||||||||||||
|
Ending balance
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Changes in AOCI by Component:
|
|||||||||||||||||||||||
|
Foreign currency translation adjustments
|
|||||||||||||||||||||||
|
Beginning balance
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Other comprehensive income (loss) before reclassification, net of tax (a)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Ending balance
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Net investment hedge
|
|||||||||||||||||||||||
|
Beginning balance
|
|
(
|
|
(
|
|||||||||||||||||||
|
Other comprehensive income (loss) before reclassification, net of tax (a)
|
|
|
|
|
|||||||||||||||||||
|
Amounts reclassified from AOCI
|
|
(
|
(
|
(
|
|||||||||||||||||||
|
Ending balance
|
|
(
|
|
(
|
|||||||||||||||||||
|
Benefit plans
|
|||||||||||||||||||||||
|
Beginning balance
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Other comprehensive income (loss) before reclassification, net of tax (b)
|
|
|
|
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|||||||||||||||||||
|
Ending balance
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Unrealized hedging gain (loss)
|
|||||||||||||||||||||||
|
Beginning balance
|
|
(
|
(
|
(
|
|||||||||||||||||||
|
Other comprehensive income (loss) before reclassification, net of tax (c)
|
|
|
|
(
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|||||||||||||||||||
|
Ending balance
|
|
(
|
|
(
|
|||||||||||||||||||
|
Total AOCI
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Three Months Ended September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| (In millions, except per share amounts) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
|
Numerator:
|
|||||||||||||||||||||||
|
Net income (loss) attributable to Visteon
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Denominator:
|
|||||||||||||||||||||||
|
Average common stock outstanding - basic
|
|
|
|
|
|||||||||||||||||||
|
Dilutive effect of performance based share units and other
|
|
|
|
|
|||||||||||||||||||
|
Diluted shares
|
|
|
|
|
|||||||||||||||||||
|
Basic and Diluted Per Share Data:
|
|||||||||||||||||||||||
|
Basic earnings (loss) per share attributable to Visteon
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Diluted earnings (loss) per share attributable to Visteon:
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Recorded Income (Loss) into AOCI, net of tax |
Reclassified from AOCI into Income (Loss)
|
Recorded in (Income) Loss | |||||||||||||||||||||||||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||||||||||||
| Three months ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency risk - Cost of sales: | |||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency derivative instruments | $ | — | $ | — | $ | — | $ | — | $ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
|
Interest rate risk - Interest expense, net:
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps |
|
|
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
Cross currency swaps
|
|
|
— |
|
|
|
|||||||||||||||||||||||||||||||||||||||||
| $ |
|
$ |
|
$ | — | $ |
(
|
$ | — | $ | — | ||||||||||||||||||||||||||||||||||||
| Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency risk - Cost of sales:
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency derivative instruments | $ | — | $ | — | $ | — | $ | — | $ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
|
Interest rate risk - Interest expense, net:
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate swaps
|
|
(
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
Cross currency swaps
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
| $ |
|
$ |
|
$ | — | $ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||
| (In millions) | 2022 | 2021 | |||||||||
| Beginning balance | $ |
|
$ |
|
|||||||
| Provisions |
|
|
|||||||||
|
Changes in estimates
|
|
|
|||||||||
| Currency |
(
|
(
|
|||||||||
| Settlements, net |
(
|
(
|
|||||||||
| Ending balance | $ |
|
$ |
|
|||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
| Net income (loss) attributable to Visteon Corporation | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization |
|
|
|
|
|||||||||||||||||||
| Provision for income taxes |
|
|
|
|
|||||||||||||||||||
| Non-cash, stock-based compensation expense |
|
|
|
|
|||||||||||||||||||
| Restructuring and impairment |
|
(
|
|
(
|
|||||||||||||||||||
| Interest expense, net |
|
|
|
|
|||||||||||||||||||
| Net income (loss) attributable to non-controlling interests |
|
|
|
|
|||||||||||||||||||
| Equity in net income of non-consolidated affiliates |
|
(
|
(
|
(
|
|||||||||||||||||||
| Other |
|
|
|
|
|||||||||||||||||||
| Adjusted EBITDA | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
| Geographical Markets | |||||||||||||||||||||||
| Europe | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Americas |
|
|
|
|
|||||||||||||||||||
| China Domestic |
|
|
|
|
|||||||||||||||||||
| China Export |
|
|
|
|
|||||||||||||||||||
| Other Asia-Pacific |
|
|
|
|
|||||||||||||||||||
| Eliminations |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
| Product Lines | |||||||||||||||||||||||
| Instrument clusters | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Information Displays |
|
|
|
|
|||||||||||||||||||
| Infotainment |
|
|
|
|
|||||||||||||||||||
| Cockpit domain controller |
|
|
|
|
|||||||||||||||||||
| Body and security |
|
|
|
|
|||||||||||||||||||
| Telematics |
|
|
|
|
|||||||||||||||||||
| Other |
|
|
|
|
|||||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||
| Three Months Ended September 30, | |||||||||||||||||
| (In millions) | 2022 | 2021 | Change | ||||||||||||||
| Net sales | $ | 1,026 | $ | 631 | $ | 395 | |||||||||||
| Cost of sales | (922) | (584) | (338) | ||||||||||||||
| Gross margin | 104 | 47 | 57 | ||||||||||||||
| Selling, general and administrative expenses | (47) | (42) | (5) | ||||||||||||||
| Restructuring and impairment | (1) | 2 | (3) | ||||||||||||||
| Interest expense, net | (2) | (2) | — | ||||||||||||||
| Equity in net income of non-consolidated affiliates | (1) | 2 | (3) | ||||||||||||||
| Other income, net | 5 | 4 | 1 | ||||||||||||||
| Provision for income taxes | (9) | (4) | (5) | ||||||||||||||
| Net income (loss) | 49 | 7 | 42 | ||||||||||||||
| Less: Net (income) loss attributable to non-controlling interests | (5) | (2) | (3) | ||||||||||||||
| Net income (loss) attributable to Visteon Corporation | $ | 44 | $ | 5 | $ | 39 | |||||||||||
| Adjusted EBITDA* | $ | 95 | $ | 42 | $ | 53 | |||||||||||
|
*
Adjusted EBITDA is a Non-GAAP financial measure, as further discussed
below.
|
|||||||||||||||||
| (In millions) | Net Sales | Cost of Sales | Gross Margin | |||||||||||||||||
| Three months ended September 30, 2021 | $ | 631 | $ | (584) | $ | 47 | ||||||||||||||
| Volume, mix, and net new business | 319 | (250) | 69 | |||||||||||||||||
| Currency | (43) | 34 | (9) | |||||||||||||||||
| Customer pricing | 125 | — | 125 | |||||||||||||||||
| Engineering costs, net * | — | (9) | (9) | |||||||||||||||||
| Cost performance, design changes and other | (6) | (113) | (119) | |||||||||||||||||
| Three months ended September 30, 2022 | $ | 1,026 | $ | (922) | $ | 104 | ||||||||||||||
| *Excludes the impact of currency. | ||||||||||||||||||||
| Three Months Ended September 30, | |||||||||||
| (In millions) | 2022 | 2021 | |||||||||
| Gross engineering costs | $ | (83) | $ | (80) | |||||||
| Engineering recoveries | 25 | 28 | |||||||||
| Engineering costs, net | $ | (58) | $ | (52) | |||||||
| Three Months Ended September 30, | |||||||||||||||||
| (In millions) | 2022 | 2021 | Change | ||||||||||||||
| Net income (loss) attributable to Visteon Corporation | $ | 44 | $ | 5 | $ | 39 | |||||||||||
| Depreciation and amortization | 27 | 27 | — | ||||||||||||||
| Provision for income taxes | 9 | 4 | 5 | ||||||||||||||
| Non-cash, stock-based compensation expense | 6 | 4 | 2 | ||||||||||||||
| Net income attributable to non-controlling interests | 5 | 2 | 3 | ||||||||||||||
| Interest expense, net | 2 | 2 | — | ||||||||||||||
| Restructuring and impairment | 1 | (2) | 3 | ||||||||||||||
| Equity in net income of non-consolidated affiliates | 1 | (2) | 3 | ||||||||||||||
| Other | — | 2 | (2) | ||||||||||||||
| Adjusted EBITDA | $ | 95 | $ | 42 | $ | 53 | |||||||||||
| Nine Months Ended September 30, | |||||||||||||||||
| (In millions) | 2022 | 2021 | Change | ||||||||||||||
| Net sales | $ |
|
$ |
|
$ | 705 | |||||||||||
| Cost of sales |
(
|
(
|
(606) | ||||||||||||||
| Gross margin |
|
|
99 | ||||||||||||||
| Selling, general and administrative expenses |
(
|
(
|
(3) | ||||||||||||||
| Restructuring and impairment |
(
|
|
(14) | ||||||||||||||
| Interest expense, net | (7) | (6) | (1) | ||||||||||||||
| Equity in net income of non-consolidated affiliates |
|
|
1 | ||||||||||||||
| Other income, net |
|
|
2 | ||||||||||||||
| Provision for income taxes |
(
|
(
|
(4) | ||||||||||||||
| Net income (loss) |
|
|
80 | ||||||||||||||
| Less: Net (income) loss attributable to non-controlling interests |
(
|
(
|
— | ||||||||||||||
| Net income (loss) attributable to Visteon Corporation | $ |
|
$ |
|
$ | 80 | |||||||||||
| Adjusted EBITDA* | $ | 245 | $ | 136 | $ | 109 | |||||||||||
|
*
Adjusted EBITDA is a Non-GAAP financial measure, as further discussed
below.
|
|||||||||||||||||
| (In millions) | Net Sales | Cost of Sales | Gross Margin | |||||||||||||||||
| Nine Months Ended September 30, 2021 | $ |
|
$ |
(
|
$ | 155 | ||||||||||||||
| Volume, mix, and net new business | 501 | (389) | 112 | |||||||||||||||||
| Currency | (76) | 66 | (10) | |||||||||||||||||
| Customer pricing | 288 | — | 288 | |||||||||||||||||
| Engineering costs, net * | — | 5 | 5 | |||||||||||||||||
| Cost performance, design changes and other | (8) | (288) | (296) | |||||||||||||||||
| Nine Months Ended September 30, 2022 | $ | 2,692 | $ | (2,438) | $ | 254 | ||||||||||||||
| *Excludes the impact of currency. | ||||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||
| (In millions) | 2022 | 2021 | |||||||||
| Gross engineering costs | $ | (245) | $ | (246) | |||||||
| Engineering recoveries | 98 | 88 | |||||||||
| Engineering costs, net | $ | (147) | $ | (158) | |||||||
| Nine Months Ended September 30, | |||||||||||||||||
| (In millions) | 2022 | 2021 | Change | ||||||||||||||
| Net income (loss) attributable to Visteon Corporation | $ | 90 | $ |
|
$ | 80 | |||||||||||
| Depreciation and amortization | 79 |
|
(3) | ||||||||||||||
| Provision for income taxes | 24 |
|
4 | ||||||||||||||
| Non-cash, stock-based compensation expense | 19 |
|
6 | ||||||||||||||
| Restructuring and impairment | 12 |
(
|
14 | ||||||||||||||
| Interest expense, net | 7 |
|
1 | ||||||||||||||
| Net income (loss) attributable to non-controlling interests | 5 |
|
— | ||||||||||||||
| Equity in net income of non-consolidated affiliates | (3) |
(
|
(1) | ||||||||||||||
| Other | 12 |
|
8 | ||||||||||||||
| Adjusted EBITDA | $ | 245 | $ |
|
$ | 109 | |||||||||||
| Exhibit No. | Description | |||||||
| 101.INS |
XBRL Instance Document.**
|
|||||||
| 101.SCH |
XBRL Taxonomy Extension Schema Document.**
|
|||||||
| 101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document.**
|
|||||||
| 101.LAB |
XBRL Taxonomy Extension Label Linkbase Document.**
|
|||||||
| 101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document.**
|
|||||||
| 101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document.**
|
|||||||
| VISTEON CORPORATION | ||||||||
| By: | /s/ Abigail S. Fleming | |||||||
| Abigail S. Fleming | ||||||||
| Vice President and Chief Accounting Officer | ||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Suppliers
| Supplier name | Ticker |
|---|---|
| 3M Company | MMM |
| Honeywell International Inc. | HON |
| Albemarle Corporation | ALB |
| RPM International Inc. | RPM |
| QUALCOMM Incorporated | QCOM |
| Chevron Corporation | CVX |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|